Ghost Tree Capital, LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 170 filers reported holding PTC THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ghost Tree Capital, LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$678,172
-97.1%
16,675
-96.7%
0.22%
-95.5%
Q3 2018$23,500,000
+3.2%
500,000
-25.9%
5.00%
-25.5%
Q2 2018$22,768,000
+320.7%
675,000
+237.5%
6.70%
+512.0%
Q1 2018$5,412,000
+35.2%
200,0000.0%1.10%
+28.8%
Q3 2017$4,002,000
+9.2%
200,0000.0%0.85%
+11.5%
Q2 2017$3,666,000
+86.3%
200,0000.0%0.76%
+107.6%
Q1 2017$1,968,000
-59.1%
200,000
+100.0%
0.37%
-76.5%
Q2 2015$4,813,000
-34.1%
100,000
-16.7%
1.56%
+18.8%
Q1 2015$7,302,000
+66.0%
120,000
+41.2%
1.31%
-37.8%
Q4 2014$4,400,000
+99.9%
85,000
+70.0%
2.11%
+76.7%
Q3 2014$2,201,00050,0001.20%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders